Atellica IM complexed PSA (cPSA)
FDA premarket approval P990055/S025 · decided 2024-02-13
Approval details
- PMA number
- P990055
- Supplement
- S025
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Atellica IM complexed PSA (cPSA)
- Generic name
- ANTIGEN(COMPLEXED),PROSTATE SPECIFIC,(CPSA)
- Applicant
- Siemens Healthcare Diagnostics
- Date received
- 2023-08-16
- Decision date
- 2024-02-13
- Days to decision
- 181 days
- Decision code
- APPR
- Product code
- NAF
- Advisory committee
- Immunology
- Expedited review
- No
- Location
- East Walpole, MA
- Statement
- Migration of the Siemens ADVIA Centaur cPSA assay to the Atellica CI analyzer.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.